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Background: Over the past two decades, the promotion of collaborative partnerships involving researchers from
low and middle income countries with those from high income countries has been a major development in global
health research. Ideally, these partnerships would lead to more equitable collaboration including the sharing of
research responsibilities and rewards. While collaborative partnership initiatives have shown promise and attracted
growing interest, there has been little scholarly debate regarding the fair distribution of authorship credit within
these partnerships.
Discussion: In this paper, we identify four key authorship issues relevant to global health research and discuss their
ethical and practical implications. First, we argue that authorship guidance may not adequately apply to global
health research because it requires authors to write or substantially revise the manuscript. Since most journals of
international reputation in global health are written in English, this would systematically and unjustly exclude
non-English speaking researchers even if they have substantially contributed to the research project. Second,
current guidance on authorship order does not address or mitigate unfair practices which can occur in global
health research due to power differences between researchers from high and low-middle income countries. It also
provides insufficient recognition of “technical tasks” such as local participant recruitment. Third, we consider the
potential for real or perceived editorial bias in medical science journals in favour of prominent western researchers,
and the risk of promoting misplaced credit and/or prestige authorship. Finally, we explore how diverse cultural
practices and expectations regarding authorship may create conflict between researchers from low-middle and high
income countries and contribute to unethical authorship practices. To effectively deal with these issues, we suggest:
1) undertaking further empirical and conceptual research regarding authorship in global health research; 2) raising
awareness on authorship issues in global health research; and 3) developing specific standards of practice that
reflect relevant considerations of authorship in global health research.
Summary: Through review of the bioethics and global health literatures, and examination of guidance documents
on ethical authorship, we identified a set of issues regarding authorship in collaborative partnerships between
researchers from low-middle income countries and high income countries. We propose several recommendations
to address these concerns.
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There has been considerable coverage in the popular
press and in academic scholarship about authorship eth-
ics including such topics as plagiarism, ghost authorship,
and even the selling of authorship [1-6]. Authorship is
very important to researchers in all disciplines because it
directly impacts decisions regarding hiring, tenure and
promotion, and awards and grants. Notwithstanding the
guidance on ethical authorship and publication practices,
several reports show that unethical authorship occurs in
upwards of 10% of cases [7,8]. Disagreement about author-
ship allocation also occurs frequently within research
teams. In a recent study of Nigerian researchers, 36.4% of
respondents reported authorship disagreements [9]. Simi-
larly, an editorial published by Zachariah et al. describes
difficulties associated with distributing authorship in re-
search teams conducting operational research in low and
middle-income countries (LMICs) [10]. These authors
note that the application of guidelines on authorship often
excludes recognition of important actors who have made
essential contributions to research in LMICs (e.g., non-
governmental organisations, policy makers). Fair distribu-
tion of authorship has also been a concern in global health
research (GHR) partnerships [11,12], where scholars from
LMICs collaborate with researchers from high-income
countries (HICs).
It is generally accepted that authorship credit should
be given to individuals who make “substantial contribu-
tions” to the design and/or conduct of research, and the
reporting of research [13]. However, many other factors
come into play during decision-making around author-
ship credit, including: disciplinary norms [14], competi-
tion [15], departmental politics [16], and favouritism
[17]. Authorship practices in the context of GHR can be
even more challenging given the variety of roles and
responsibilities of researchers from LMICs and HICs.
Ultimately, various factors may contribute to, or influ-
ence authorship decisions.
The aim of this paper is to explore issues relating to
authorship practices in GHR partnerships and to propose
recommendations. We limit our focus on partnerships in
which authors from LMICs collaborate with researchers
from HICs. We begin by providing important background
information including the general context of global health
research and authorship as well as current norms or
guidelines concerning authorship. We then consider four
specific issues related to authorship, namely: language
barriers limiting opportunities for authorship attribution;
the lack of guidance for ranking authors; the risk of gift
authorship linked to perceptions of editorial bias for
well-known researchers from English-speaking HICs;
and, the impact of diverse cultural understandings and
expectations regarding research contribution and own-
ership. The two former issues are linked to authorshipshortcomings regarding authorship recommendations
outlined in the International Committee of Medical Journal
Editors (ICMJE) authorship guidance while the latter two
concern authorship practices more generally. While some
issues may appear to be practical in nature, we will dem-
onstrate that they often have significant ethical conse-
quences. To address the ethical and practical concerns
about authorship in GHR partnerships, we recommend
further research on norms and practices in GHR set-
tings, additional training for researchers, and finally, im-
proved guidance.
Discussion
The context of authorship in global health research
Global health “places a priority on improving health and
achieving equity in health for all people worldwide” and
“emphasizes transnational health issues, determinants
and solutions.” ([18], p.1995). Research in the field of global
health is often multi or interdisciplinary and is highly col-
laborative [18]. For the purposes of this paper, the focus
will be on a specific subset of partnerships in global health:
situations where LMIC and HIC researchers collaborate as
members of multi- or interdisciplinary research teams, and
where authorship is attributed to many individuals, each
responsible for specific tasks. These collaborative partner-
ships bring together researchers from LMICs and HICs to
share and maximize their diverse expertise, experiences,
and perspectives within a knowledge network. For ex-
ample, researchers from HICs and LMICs may obtain a
grant to study the genetics of a tropical disease. HIC
researchers may have scientific expertise and access
to state-of-the-art technology required for the study.
LMIC researchers from countries affected by this dis-
ease can provide scientific expertise, as well as valuable
insight and knowledge respecting local realities and
needs; they are also likely to have easier access to, and
be more easily accepted by, research participants and
local institutions than are “outsiders” [19]. Together
they may be able to develop epidemiological genetic
information that can lead to more effective public health
interventions to treat the targeted disease.
Such partnership collaborations have been promoted,
in part, to counter inequality and imbalance in GHR
where researchers from HICs have not always studied
topics of relevance to local communities in LMICs [20].
For GHR projects undertaken in LMICs, funders and re-
search ethics boards often require that the research ad-
dress local interests and needs. Accordingly, researchers
involved in GHR partnerships are increasingly being held
ethically responsible to support “community collaboration
and engagement” [20].
While many researchers and commentators have ac-
knowledged the laudable goals and benefits of such
GHR partnerships, they have also pointed out practical
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challenges include power inequities, communication bar-
riers, diverging research priorities, as well as important
differences in research cultures [21]. Even if there is little
wide scale empirical evidence, the allocation of research
credit through authorship is a key issue that is often raised
[9-12]. It remains, however, unclear how authorship is or
should be appropriately reflected through the order of
attribution.
Authorship policies in GHR
Various organisations such as the ICMJE [13], World As-
sociation of Medical Editors (WAME) [22] and the Com-
mittee on Publication Ethics (COPE) [23] have discussed
ethical authorship and publication considerations in scien-
tific manuscripts. However, health-based researchers and
journals have not as yet consistently applied current guid-
ance [24]. COPE mentions that editors should adopt guid-
ance related to authorship, but does not propose specific
criteria on authorship [23] and WAME provides very gen-
eral guidance recommending that all authors make “sub-
stantial intellectual contribution” [22]. The ICMJE has set
out more specific detailed authorship recommendations.
ICMJE lists the following criteria for authorship:
1. Substantial contributions to the conception or
design of the work; or the acquisition, analysis, or
interpretation of data for the work; AND
2. Drafting the work or revising it critically for
important intellectual content; AND
3. Final approval of the version to be published; AND
4. Agreement to be accountable for all aspects of the
work in ensuring that questions related to the
accuracy or integrity of any part of the work are
appropriately investigated and resolved ([13], p.2).
While ICMJE authorship recommendations may at first
glance seem onerous, they aim to ensure that all re-
searchers who are authors are engaged throughout the life
cycle of the research project including conducting the re-
search, drafting, revision and approval of the article, and
accepting responsibility for the work. While the ICMJE
recommendations have been and are still at times the sub-
ject of criticism, they have become the leading standard in
health science research, including GHR [24-26].
Issues regarding authorship in GHR
Satisfying authorship criteria for researchers with
limited English language abilities Although the ICMJE
recommendations are reflected in many scientific codes
of ethics and have been adopted by many journals [24],
they do not adequately address the more complex na-
ture of research collaborations where contextual factors
influence whether every researcher contributes to, orparticipates in, the entire research process. This is par-
ticularly true in GHR where language abilities may pose
significant barriers.
In GHR partnerships, HIC researchers are more likely
to have stronger English language abilities than their col-
leagues in LMICs. The latter may be at a distinct disad-
vantage in drafting part of or an entire article for English
health sciences publications, or critically revising it for
important intellectual content (ICMJE criterion 2). While
it is possible to publish in scientific journals in languages
other than English, these journals are less likely to be in
international databases and would not receive similar
international readership or exposure [27].
If LMIC researchers are unable to draft or critically
revise the article, they would technically fail to satisfy
the ICMJE recommendations for authorship. Thus a re-
searcher who may have substantially contributed to the
research by participating in the study’s conception or de-
sign, or the acquisition, analysis or interpretation of data
(thereby satisfying condition 1), may not be named as
author due to a lack of English reading and writing skills.
Having a non-English speaking individual draft the art-
icle in their native language with the aid of a profes-
sional translator might prove burdensome because of
the substantial translation costs, and would also necessi-
tate the verification of the translated text by a native
English speaker to ensure its accuracy. Consider as well,
that most free online translation tools are fraught with
errors, requiring massive edits by the English-speaking
author or payments for additional editorial services. Due
to financial costs and the added time required, many re-
searchers may be reluctant to pursue such steps to sat-
isfy ICMJE criteria.
The ICMJE recommendations clearly state that
[…] the criteria are not intended for use as a means to
disqualify colleagues from authorship who otherwise
meet authorship criteria by denying them the
opportunity to meet criterion #s 2 or 3. Therefore, all
individuals who meet the first criterion should have
the opportunity to participate in the review, drafting,
and final approval of the manuscript [13].
Providing adequate opportunity is a fundamental
principle in the ethics of science and helps to prevent dis-
crimination based on gender, race, and sexual orientation
[28]. However, LMIC researchers may still fall short of
satisfying all four ICMJE criteria even if ample opportunity
is given to write, revise and approve the manuscript
because of limited knowledge of the English language.
In a similar vein, all researchers who are authors need
to be accountable for the work as indicated in ICMJE
criterion 4, and to do this they need to satisfy criterion 3
and approve the final version of the text to be published.
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be able to partially satisfy criterion 3 using online trans-
lation tools. But similar to the point made above, trans-
lation generated by these tools is far from flawless and
language discrepancies are likely to result in a loss in
translation. While not a perfect approach, online transla-
tion tools will often be sufficient to allow researchers
who cannot read in English to approve the final version
of the article and be accountable for the published work.
However, even if ways are found to satisfy criteria 3 and
4, criterion 2 – drafting the work or revising it critically
for important intellectual content – will be much more
difficult for non-English writing researchers to satisfy for
English publications. To limit the shortcoming of transla-
tion tools, the manuscript’s revision could be achieved
through verbal discussions in order to ensure that all re-
searchers agree that the manuscript properly conveys the
research. The notion of “revising the article critically” (as
stated in ICMJE criterion 3) could be interpreted differ-
ently in the GHR context to mean “reviewing” the article
for important intellectual content so that there is less
dependence on LMIC authors’ English writing abilities.
In this sense, the LMIC author, like any other author, is
still engaged in the drafting and review process of the
manuscript and is still contributing in substantial ways
to the research. Further examination is warranted as to
how current ICMJE guidelines could contribute to system-
atic exclusion of some GHR researchers from authorship
based on language ability. Ultimately, the aforementioned
and other amendments to ICMJE should be given further
consideration in order to avoid unfair exclusion of authors
based on language.
Ranking authors in GHR collaborations The ICMJE
recommendations state that authorship decisions should
be made by all authors as a group, and that the corre-
sponding author “should be prepared to explain the pres-
ence and order of these individuals” [29]. This does not
suffice to address the complexities of GHR collaborations.
In the health sciences more generally, authorship is
often attributed in descending order of contribution [3]
although other methods may also be applied (e.g., alpha-
betical order, principal investigator/team leader being
senior last author) making distribution quite variable
[30]. Moreover, ranking would most likely not apply
when a number of authors have contributed more or less
equally. The comparative assessment of contributions
may also be tricky for different types of work (e.g., tech-
nical tasks or conceptual contributions to the design of
research). Since GHR collaborations are often interdis-
ciplinary, other distribution methods from various disci-
plines may also be considered, including alphabetical
order [31]. In large teams where ranking is complex be-
cause many have contributed relatively evenly, a mixedmethod of ordering may be applied: the first few authors
are listed according to the importance of contribution in
descending order, while others are named in alphabetical
order. In the interest of accuracy and transparency, an
asterisk may be added with a disclaimer mentioning that
certain individuals have contributed equally. Akhabue
and Lautenback’s empirical study on equal credit in top
medical journals shows that disclaimers were a growing
trend in medical journals from 2000 to 2007 [32]. Diver-
sity in naming authors might be due to the fact that norms
regarding ranking have never been formally codified.
The lack of guidance respecting authorship order in
general can also be applied in GHR collaborations and
could potentially create confusion and lead to insufficient
recognition of LMIC researchers. For example, LMIC re-
searchers may be given reduced ranking on the author
byline because their contributions to subject recruitment,
data collection, administration and analysis are catego-
rized as “technical tasks” and may be considered of lesser
value than drafting the manuscript. This reduced author-
ship ranking is ethically problematic because it may place
LMIC researchers at a disadvantage, which could nega-
tively affect their career prospects, access to research
funds, and the scholarly recognition they deserve.
Unfairness stemming from a lack of clear ranking
methods may also be the effect of power differentials
within and between teams. HIC researchers are often
better positioned to obtain the funding essential to GHR
projects. Funding eligibility for the team may be deemed
more valuable in securing resources. Consequently, indi-
viduals from LMICs with less funding leverage might
accept, or feel obliged to accept, a lower ranking of author-
ship, even when their contribution is more substantive and
deserving of higher authorship ranking. Power differentials
often linked to research financing is certainly an issue in
many contexts of research [33]. However, in partnerships
between HIC and LMIC researchers, power differential are
likely more pronounced because of greater discrepancies in
access to research funds.
In order to address differences in types of contribu-
tions and mitigate disadvantages to LMIC researchers,
some research teams have elected to alternate the order
of authors based on geographic origin instead of main-
taining the extent of contribution as the sole determin-
ing factor in ranking. For example, in an HIV study in
Guatemala, the authors elected to alternate their names
based on their geographic location (e.g., one author from
Canada, one from Guatemala, etc.) [34]. The intent is to
recognize the amount of contribution of each author, as
well as to address the reality that the contributions of
LMIC contributors might, by their very nature, receive
lower authorship recognition than those made by HIC
contributors. While seeking to address issues of equity in
GHR partnerships, concerns about fairness would arise
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fered extensively.
In an attempt to level the playing field, HIC researchers
may provide greater visibility and opportunity to re-
searchers in LMICs by offering authorship or a higher
ranking than was deserved based on contribution alone.
The rationale behind this may be similar to that found in
affirmative action or redistributive justice programs which
seek to compensate for past and/or present discrimination
or bias. It may indeed put LMIC researchers on a more
equal footing with HIC researchers. However, it is far from
clear that authorship – which should establish responsibil-
ity and accountability for research [35] – is the appropri-
ate method to level this playing field. Building research
capacity in LMICs, providing more opportunities for
LMIC researchers to contribute to research, and expand-
ing the possibility of LMIC researchers to secure grant
funding, are more promising means to bring balance than
undeserved authorship.
The use of a disclosure statement to explain author-
ship order can be effective in clarifying and justifying
authorship order, or to avoid misinterpretations. Disclos-
ure statements (or “contributorship”) usually outline the
contribution of individuals in research design, data col-
lection and analysis, and drafting; however, they are lim-
ited in that such declarations do not clearly indicate how
authors were ranked based on the amount of work or its
level of difficulty [35]. Regardless of such shortcomings,
declaring author contributions has increased transpar-
ency regarding the type of work of each individual. Cer-
tainly, further discussion about effective strategies for
authorship ordering in GHR is needed in order to estab-
lish fairness and opportunity for all team collaborators.
Perceived editorial bias may promote unethical
authorship practices The underrepresentation of re-
search from LMICs in peer-reviewed journals is well
documented [36-39]. There are a number of reasons to
explain this situation, such as the lack of infrastructure;
inadequate human and financial resources in LMICs [40];
weaknesses in manuscript preparation (presentation, logic,
language); and limited access to scientific literature [37].
Several studies suggest that there may also be an inherent
bias by journal editors who favour research from English
speaking researchers [4,41-44]. However, when discussing
the potential bias in favour of well-known or “star” au-
thors, Godlee and Dickersin report that “the available evi-
dence is patchy […] and inconclusive” [45], p.96.
Regardless of whether editorial bias regarding well-
known authors is widespread or not, certain researchers
might believe in the existence of such bias. This percep-
tion could incentivise researchers from LMICs to bestow
“prestige authorship” upon their collaborators from HICs
by offering them senior author or primary (first) authorpositions. Researchers may think that this helps their
chances of getting the paper accepted for publication. Re-
searchers from HICs could use the same rationale and ad-
vocate that they should be given primary or senior author
positions, arguing that it will increase the likelihood of
having the paper accepted in a high impact journal.
Several strategies have been implemented to address
the underrepresentation of research from LMICs. Jour-
nals provide editing services for non-English authors
[46,47]; space is devoted to local research on issues rele-
vant to specific regions; certain costs are subsidized for
LMIC researchers and institutions [48]; and open access
journals provide waivers for authors from LMICs [49].
While these initiatives are laudable, they do not eliminate
perceptions of editorial bias for prominent well-known,
English speaking researchers. Researchers from LMICs
may still decide to provide prestige authorship to their
HIC counterparts irrespective of measures to increase ac-
cess and reduce costs associated with publication. It is ne-
cessary to look for other means to address this potential
bias. Perhaps open discussion of this topic to reduce mis-
conceptions may help avoid such issues. It might also be
warranted to ask why such perceptions may be present
and to assess empirically the extent to which such percep-
tions actually influence authorship practices.
Differing values and practices related to research
integrity Most research on the responsible conduct of
research (RCR) comes from HICs – more specifically the
US – and only recently are we learning about RCR prac-
tices in LMICs [50]. Consequently, the values, practices
and principles defining research integrity mainly reflect
the social norms and values in HICs, and do not always
adequately take into consideration the norms and values
of LMIC researchers. There is also little research docu-
menting cultural differences and the related perceptions
and norms of research integrity across different countries
and regions for both HICs and LMICs. Cultural differ-
ences between GHR collaborators are likely to play an
important role in authorship decisions and may explain
some authorship practices that fall outside ICMJE recom-
mendations. Cultural differences can lead to conflicting
views or positions regarding RCR. In some cultural con-
texts, it may be deemed appropriate or even required to
give authorship credit out of respect (e.g., to senior col-
leagues, or directors of institutes). Of course, this runs
counter to norms and practices endorsed by guidance
documents like the ICMJE.
Gender bias might also lead to unethical authorship
practices in GHR collaborative partnerships. In some set-
tings, women may be less likely to be named authors in
research publications as often as men even if they have
made the same contributions to the project. For example,
one study found that black women in South Africa are
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sitions in collaborative publications [51]. While the rate of
women conducting research and publishing in South
Africa has increased during the last 20 years [52], there
remains significant underrepresentation of women in
scientific authorship. More knowledge is needed to truly
understand the effect of gender bias on authorship distri-
bution in GHR.
As GHR is often undertaken by multi/interdisciplinary,
international teams comprised of researchers from a var-
iety of backgrounds and cultures, there is likely to be diver-
gence respecting authorship practices and expectations.
These differences may lead to conflicts within GHR teams
or questionable authorship practices, which in turn may
jeopardize future collaborations, or tarnish reputations and
careers. Global health researchers especially need to be
mindful of these differences. Disputes over authorship in
GHR collaborative teams can be minimized and may be
handled more collegially if they are discussed openly at the
outset of a project [53]. Increased awareness of cultural dif-
ferences among GHR team members is important in order
to establish a reciprocal understanding of the views of re-
searchers from different cultures, and facilitate negotiations
and buy-in with respect to authorship decisions.
Recommendations for ethical authorship in GHR
We recommend three initiatives to begin addressing
authorship issues related to GHR collaborative partner-
ships: (1) to undertake research on research integrity
(RRI) with a focus on authorship in GHR, (2) to increase
awareness and understanding in the research community
about authorship issues in the GHR context, and (3) to
strengthen ethical guidance on authorship in GHR.
Research on authorship norms and practices in GHR
settings
Performing conceptual as well as empirical RRI is a neces-
sary preliminary undertaking to understand the norms,
values, and practices of authorship specific to GHR. RRI
will address descriptive questions such as how authorship
is allocated, how authors are ranked, and what factors
influence authorship decisions. Policy related questions
would include the following: Are current authorship stan-
dards sufficient? Do we need to reform authorship cri-
teria? What should be the basis for authorship ordering in
GHR? Description of GHR practices might help us under-
stand how authorship is distributed and how researchers
perceive important topics related to authorship such as re-
sponsibility and merit.
Educating researchers about authorship in the GHR context
Raising awareness about ethical authorship can be done
through RCR education. Given the relatively high preva-
lence of authorship issues and disputes [7-9], and thelikelihood that researchers will face authorship issues early
in their careers, training on authorship ethics should be
included in graduate studies. This would introduce stu-
dents to a culture of research integrity at the outset of
their research careers and help them to better recognize
problematic issues and understand the implications of
unethical conduct. Training can lead to better under-
standing, negotiation and acceptance regarding author-
ship at the outset of a project to prevent or mitigate
reduced morale and conflict about authorship. More spe-
cifically, in practice, researchers may learn a variety of eth-
ical ways to distribute authorship in GHR by providing
opportunity for contributors to become authors without
creating systematic disadvantages or unfairness.
Education programs used to promote RCR vary con-
siderably between countries [50,54]. While RCR training
is obligatory in the U.S. for all NIH funded researchers
[55,56], it is not implemented systematically in all HICs
[54]. We have also not identified any systematic educa-
tion programs in LMICs. However, more empirical re-
search is necessary to document ongoing initiatives that
have not yet been reported in the literature. While there
is a general trend toward greater international cooper-
ation and harmonization respecting RCR [57], there is
little information concerning authorship in the context
of GHR partnerships in educational material. This gap
may be related to the limited knowledge about specific
authorship practices in GHR partnerships, as well as
sparse policy guidance. Therefore, in addition to educat-
ing researchers about authorship generally, there is a
pressing need for training that addresses authorship is-
sues in GHR partnerships. Course curricula should be
inclusive and relevant to both HIC researchers and
LMIC researchers who participate in GHR partnerships.
This approach is consistent with the notion of collab-
orative partnership.
Strengthening guidance on authorship in GHR settings
A growing number of health science journals have adopted
the ICMJE recommendations in their policies [24,58]. The
ICMJE recommendations help bring clarity, and provide
useful reference points for the development and enhance-
ment of authorship practices. However, it should be noted
that GHR researchers are not primarily focused on trying
to remedy broad or systemic inequities associated with
authorship allocation. Rather, they are focused on con-
ducting good science, answering relevant research ques-
tions, and advancing their careers within established
norms and practices.
Despite the worthy efforts of the ICMJE, there may be
circumstances in which global health researchers reason-
ably deserve credit for their contributions, but do not
satisfy all of the authorship criteria; as well, they may be
exposed to unethical authorship practices i.e., prestige or
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an attempt to acknowledge various researchers in GHR,
some may opt to follow ICMJE and simply list other
major contributors in the acknowledgement section. Yet
this may be considered ethically problematic to the ex-
tent that these practices reflect a systematic disadvantage
of LMIC researchers. Perhaps the necessity of “critically
revising” or drafting a paper is simply not always realistic
in the case of GHR. Alternatively, it may be appropriate
to give authorship credit for critically reviewing the
paper and ensure accountability through signed attesta-
tions of one’s contribution (e.g., data collection, analysis,
writing and review).
As stated previously, authorship policies that address
GHR collaborations should be founded on empirical data
and conceptual research of authorship norms, values and
practices. Expanding authorship policies to be more re-
sponsive to the GHR context is important for GHR re-
searchers from both HICs and LMICs. This policy base is
essential in guiding the development of best practices to
address or counter disproportionate advantage due to
geographic location, language ability, academic affiliation,
institutional reputation, and access to resources in GHR
collaborations. Best practices are not meant to be restrict-
ive; quite the contrary, they serve to pre-empt potential
issues and help ensure consistency in the ethical practice
of authorship assignment and ranking. Many key actors
should be involved in this important discussion regarding
authorship guidance including researchers, funding agen-
cies, scientific societies, and journal editors.
Summary
In this paper, we report and discuss potential ethical
issues related to authorship attribution in GHR. Despite
the growth of GHR collaborative partnerships, very little
has yet been done to understand the ethical underpin-
nings of fair authorship practices in this setting. Deficiency
in authorship policies, perceptions of bias, and cultural
differences are likely to contribute to questionable or un-
ethical authorship practices in GHR settings. To address
these issues and promote ethical authorship practices,
several strategies should be pursued. Further conceptual
and empirical research is needed to better understand
authorship practices in GHR. Responsive and applicable
authorship policies for GHR should be developed. Fi-
nally, training should be implemented to share know-
ledge and expose researchers to authorship norms and
practices in GHR. If authorship issues are not dealt
with, they may not only undermine the integrity of re-
search, demoralize researchers, and damage important
future GHR collaborations.
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